Cytokinetics

CYTK

CYTK
Cytokinetics Stock Quote
$10.61 -$0.18 -1.7%
BATS BZX Real Time Price as of May 22, 2019, 3:31 p.m. View Interactive CYTK Charts

A biopharmaceutical company, focused on developing small molecule therapeutics for the treatment of cardiovascular diseases and cancer.

News & Analysis: Cytokinetics

All

Market Moves

Earnings








Biotech 101: Valuing Binary Events

Sarepta Therapeutics, Revance Therapeutics, and Cytokinetics saw big moves recently; MannKind and Orexigen could be next.




Interactive Chart